Aurobindo Pharma Paroxetine
MAP's drug, Levadex, showed statistical significance at two hours compared to placebo at relieving common symptoms of migraine: pain, nausea, and sensitivity to light and sound.
Levadex, formerly called MAP0004, also reached secondary measures of the 792-patient trial, including pain relief at 30 minutes and sustained relief for 48 hours.
Read moreMore information on "Aurobindo Pharma Paroxetine"
From Our Experts
Medications for Bipolar: Paxil (Paroxetine)
Paxil - generic paroxetine - is an antidepressant that works by increasing the amount of serotonin between nerve cells in the brain, which... Read more »
Question of the Week: What Do You Think of Pharma?
In a month or so I'm going to "represent" at a conference for heath professionals and pharmaceuticals. They want to know how the online MS... Read more »
Big Pharma and Licensing Drug Sales Reps
Big Pharma – the worldwide multibillion-dollar drug industry – does us a huge service by curing our ills. Unfortunately, its... Read more »
Diabetes Research and Pharma Companies
Reprinted with permission of Amy Tenderich of DiabetesMine.com One thing about the ADA Conference last month that I haven't gotten... Read more »
Patient Voices in the Multiple Sclerosis Community
Last November we had a lively discussion regarding FDA, Social Media, and Pharmaceutical Advertising. The consensus seemed to be that we... Read more »
From Our Sources
New asthma med filed for FDA approval
British drugmaker SkyePharma has filed a new drug application with the FDA for Flutiform (fluticasone propionate-formoterol fumarate). The... Read more »
Clinical trial: GW679769 and Paxil in adults with social anxie...
This is a study to determine the safety and effectiveness of a new medicine (GW679769) and paroxetine (Paxil) in adults with social anxiety disorder.... Read more »
Norplant
Source: HealthCentral Encyclopedia
One of the newest birth control options for women is literally at arm's reach. The Norplant contraceptive, approved by the Food and Drug... Read more »
Clinical trial: LY686017 versus Paxil in treating social anxie...
This is a study to compare a new drug, LY686017, with Paxil (paroxetine) and a placebo in the treatment of social anxiety disorder. This national... Read more »
Generic Imitrex gets tentative OK
The U.S. Food and Drug Administration has given tentative approval to a generic form of the migraine medication Imitrex. The tentative approval is a... Read more »
Featuring Content From:
By using this service, you accept our Terms of Use. Please read them. The consumer health information on is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen. Copyright © 2012 Remedy Health Media, LLC. All Rights Reserved.
